PROUDLY SPONSORED BY:
Allergan
Allergan plc (NYSE: AGN), an AbbVie Inc (NYSE: ABBV) company, is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics. https://www.abbvie.com/allergan.html
Novaliq Gmbh
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free eye drop technology. Novaliq offers an industry-leading portfolio addressing today’s unmet needs of millions of patients with eye diseases. Novaliq is headquartered in Heidelberg. www.novaliq.com
Kala Pharmaceuticals
Kala is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. Kala has applied its proprietary AMPPLIFY Drug Delivery Technology to a corticosteroid, loteprednol etabonate (LE), designed for ocular applications, resulting in the August 2018 FDA approval of INVELTYS® for the treatment of inflammation and pain following ocular. www.kalarx.com
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class therapeutic candidates to address large market opportunities initially in ophthalmic conditions where there are limited treatment alternatives, starting with Demodex blepharitis. Tarsus was founded in 2017 and is headquartered in Irvine, California. www.tarsusrx.com
Novaliq Gmbh
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free eye drop technology. Novaliq offers an industry-leading portfolio addressing today’s unmet needs of millions of patients with eye diseases.
Company's Website
Kala Pharmaceuticals
Kala is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. Kala has applied its proprietary AMPPLIFY Drug Delivery Technology to a corticosteroid, loteprednol etabonate (LE) and designed for ocular applications.
Company's Website
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class therapeutic candidates to address large market opportunities initially in ophthalmic conditions where there are limited treatment alternatives, starting with Demodex blepharitis.
Company's Website
MEDIA PARTNER:
AGENDA | AUGUST 20
1:00 - 1:10 PM
Welcome and Dry Eye Overview
Presented By:
Paul Karpecki, OD, FAAO, Associate Professor - UPike College of Optometry/Kentucky Eye Institute
1:10 - 2:11 PM
Company Showcase
Novaliq GmbH | Sonja Krösser PhD, VP, Preclinical & Clinical Development
AdOM Advanced Optical Technologies | Raanan Gefen, Managing Director
Kala Pharmaceuticals | Kim Brazzell, PhD, Chief Medical Officer
20/20 OptimEyes Technologies | Frances Lasowski, PhD, CEO
Tarsus Pharmaceuticals | Bobak Azamian, MD, PhD, CEO
Eyedetec Medical | Barry Linder, MD, President & CEO
Olympic Ophthalmics | Laura M Periman, MD, Periman Eye Institute
Ocunova | Michael Shine, CEO
2:11 - 3:00 PM
The Dry Eye Outlook Panel
Panelists:
Whitney Hauser, OD, FAAO, Founder - Signal Ophthalmic Consulting
Marguerite McDonald, MD, FACS - OCLI (Ophthalmic Consultants of Long Island)
Joseph Tauber, MD, CEO - Tauber Eye Center
William Trattler, MD, President - Center for Excellence In Eye Care
Moderated By:
Paul Karpecki, OD, FAAO, Associate Professor - UPike College of Optometry/Kentucky Eye Institute